CLINICAL_TRIALS
trial_result
· 2007-07-30
Clinical Trial Update: Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents [Phase 3]
Summary
Pfizer-sponsored Phase 3 transition study evaluating growth hormone therapy in adolescents with partial growth hormone deficiency has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Growth Hormone Deficiency | Phase 3 | Status: COMPLETED